Medical University of Vienna, Austria
"I graduated with a master’s degree in Chemistry and Pharmaceutical Techniques from the University of Padua, Italy. I completed my master’s thesis with the Swiss-European mobility program at the University of Geneva, Switzerland. I had the opportunity to work on the discovery of novel small molecule-based treatments for Alport syndrome, a rare disease that inevitably leads to kidney failure. We designed a small library of possible antagonists for serotonin receptor; from the computational analysis, we then selected the two most promising molecules to chemically synthesize. I quickly became very interested in computational techniques because of their dynamical and interdisciplinary role at the interface between the molecular and biological worlds. In order to gain further experience in molecular modeling, I attended a six-month graduate research fellowship in a biotech company, in collaboration with the University of Padua. The project focused on the computational study of voltage-gated potassium channels involved in epilepsy. The presence of underlying common patterns between different receptor systems triggered my interest in computational structural biology and inspired me to join NeuroTrans program in the study of neurotransmitter transporters for central nervous system disorders."